Predicting buprenorphine adherence among patients with opioid use disorder in primary care settings

被引：0
|
作者：
Stephanie A. Hooker [1 ]
Colleen Starkey [1 ]
Gavin Bart [2 ]
Rebecca C. Rossom [1 ]
Sheryl Kane [1 ]
Anthony W. Olson [3 ]
机构：
[1] HealthPartners Institute,
[2] Research and Evaluation Division,undefined
[3] Hennepin Healthcare,undefined
[4] Essentia Institute of Rural Health,undefined
来源：
BMC Primary Care | / 25卷 / 1期
关键词：
Substance-related disorders; Adherence; Medications for opioid Use Disorder; Outpatient treatment;
D O I：
10.1186/s12875-024-02609-9
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Increasing Access to Buprenorphine for Opioid Use Disorder in Primary Care: an Assessment of Provider Incentives
    Kelley, A. Taylor
    Wilcox, Jordynn
    Baylis, Jacob D.
    Crossnohere, Norah L.
    Magel, John
    Jones, Audrey L.
    Gordon, Adam J.
    Bridges, John F. P.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 (09) : 2147 - 2155
  • [22] Social Determinants of Health and Continuity of Medications for Opioid Use Disorder Among Patients Receiving Treatment in Rural Primary Care Settings
    Pham, Huyen
    Ober, Allison
    Baldwin, Laura-Mae
    Mooney, Larissa J.
    Zhu, Yuhui
    Fei, Zhe
    Hser, Yih-Ing
    JOURNAL OF ADDICTION MEDICINE, 2024, 18 (03) : 331 - 334
  • [23] eComparison of oral buprenorphine/naloxone, depot buprenorphine and methadone for patients released from custodial settings with opioid use disorder
    Shi, Avelyn
    Naz, Rokshar
    Hanby, Matthew F.
    McKenzie, Cameron R. L.
    Moe, Syed
    Dunlop, Adrian J.
    DRUG AND ALCOHOL REVIEW, 2023, 42 : S164 - S164
  • [24] Associations of retention on buprenorphine for opioid use disorder with patient characteristics and models of care in the primary care setting
    Bailey, Steffani R.
    Lucas, Jennifer A.
    Angier, Heather
    Cantone, Rebecca E.
    Fleishman, Joan
    Garvey, Brian
    Cohen, Deborah J.
    Rdesinski, Rebecca E.
    Gordon, Leah
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 131
  • [25] Use of a Benchmark Tracking Assessment to Support Expansion of Buprenorphine for Treatment of Opioid Use Disorder in Primary Care
    Sussman, Andrew L.
    Crawford, Jennifer N.
    Brakey, Heidi Rishel
    Alkhafaji, Rana S.
    Myers, Orrin B.
    Jacobsohn, Vanessa
    Bhatt, Snehal
    Salvador, Julie
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2021, 34 (06) : 1216 - 1220
  • [26] Adherence to buprenorphine treatment guidelines among individuals with an opioid use disorder who have private insurance
    Mark, Tami L.
    Hinde, Jesse M.
    Zarkin, Gary A.
    Parish, William
    Kluckman, Marianne
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 116
  • [27] Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder
    Ronquest, Naoko A.
    Willson, Tina M.
    Montejano, Leslie B.
    Nadipelli, Vijay R.
    Wollschlaeger, Bernd A.
    SUBSTANCE ABUSE AND REHABILITATION, 2018, 9 : 59 - 78
  • [28] Using buprenorphine to treat patients with opioid use disorder
    Radi, Joshua K.
    Fogarty, Kieran J.
    Lagerwey, Mary D.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (10): : 30 - 35
  • [29] Primary care for opioid use disorder
    Mannelli, Paolo
    Wu, Li-Tzy
    SUBSTANCE ABUSE AND REHABILITATION, 2016, 7 : 107 - 109
  • [30] The Next Stage of Buprenorphine Care for Opioid Use Disorder Response
    Martin, Stephen A.
    Chiodo, Lisa M.
    Bosse, Jordon D.
    Wilson, Amanda
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (11) : 821 - 822
12345